Go Pro

Bolt Biotherapeutics (BOLT) News Today

Bolt Biotherapeutics logo
$3.92 +0.07 (+1.82%)
As of 08/26/2026 03:59 PM Eastern

Bolt Biotherapeutics Latest News

Bolt Biotherapeutics Announces Major Restructuring Plan
Bolt Biotherapeutics reports Q4 EPS (42c), consensus (35c)
Bolt Biotherapeutics price target lowered to $1.25 from $1.50 at Stifel
Bolt Biotherapeutics Reports Q3 2024 Financial Results

Bolt Biotherapeutics Media Mentions By Week

Bolt Biotherapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BOLT
News Sentiment

1.44

0.87

Average
Healthcare
News Sentiment

Bolt Biotherapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BOLT Articles
This Week

2

2

BOLT Articles
Average Week

Bolt Biotherapeutics Trends on MarketBeat

This week vs. last week
Searches
2
+100%
Page Views
1,015
+8%
Get Bolt Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Bolt Biotherapeutics dated 8/11/2026.
From Our Partners